Comments Requested: Proposed Drug Pricing Changes for Medicare Advantage (MA) and Part D Plans – January 25. CMS solicits public comments on potential Medicare policies intended to lower costs for beneficiaries and to provide MA and Part D plans with tools to lower the cost of prescription drugs. Proposals include requiring Part D Explanation of Benefit statements to list drug pricing information, restricting Part D plans from prohibiting or penalizing a pharmacy from disclosing a lower cash price to an enrollee, and redefining the negotiated price paid to pharmacies. Rural pharmacies report that payments from Part D plans are a major concern that affect their financial viability.
